Meridian Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,834
Closed -$535K – 113
2026
Q2
$535K Buy
5,834
+224
+4% +$19.6K 0.06% 65
2026
Q1
$478K Buy
+5,610
New +$500K 0.07% 69
2021
Q4
– Sell
-4,087
Closed -$308K – 84
2021
Q3
$308K Buy
4,087
+22
+0.5% +$1.75K 0.07% 54
2021
Q2
$330K Hold
4,065
– – 0.08% 50
2021
Q1
$320K Sell
4,065
-358
-8% -$28.1K 0.1% 49
2020
Q4
$378K Buy
4,423
+3
+0.1% +$248 0.16% 38
2020
Q3
$341K Sell
4,420
-38
-0.9% -$2.9K 0.17% 36
2020
Q2
$327K Buy
4,458
+3
+0.1% +$213 0.18% 37
2020
Q1
$296K Buy
4,455
+4
+0.1% +$282 0.18% 41
2019
Q4
$306K Hold
4,451
– – 0.19% 37

Other funds holding CL

Meridian Wealth Partners's CL Position: Q3 2026 in Review

Meridian Wealth Partners sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 5,834 shares — an estimated $535K sold.

Meridian Wealth Partners first reported a position in CL in Q4 2019 and held it in 10 quarters. The position peaked at $535K in Q2 2026. 1,966 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Meridian Wealth Partners reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Meridian Wealth Partners sold 5,834 Colgate-Palmolive shares in Q3 2026, an estimated $535K.
  • Meridian Wealth Partners first reported a position in Colgate-Palmolive in Q4 2019 and held it in 10 quarters.
  • Meridian Wealth Partners's Colgate-Palmolive position peaked at $535K in Q2 2026.
  • 1,966 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Meridian Wealth Partners's 13F filing for Q3 2026, filed 9 Nov 2026.